Structural Information. Array shall not disclose the structure of any Optimization Compound, Derivative or Product (to the extent such structure is not publicly available) to any Third Party nor identify such structure, if publicly available, with its collaboration with ICOS without ICOS's written permission, unless required to do so by law, in which case Array shall promptly notify ICOS of such required disclosure and will use its reasonable efforts to assist ICOS to secure confidential treatment of such structure prior to any disclosure.
Appears in 3 contracts
Samples: Discovery Collaboration Agreement (Array Biopharma Inc), Lead Optimization Agreement (Array Biopharma Inc), Drug Discovery Collaboration Agreement (Array Biopharma Inc)
Structural Information. Array shall not disclose the structure of any C3 Optimization Compound, Derivative or Product (( to the extent such structure is not publicly available) to any Third Party nor identify such structure, if publicly available, with its collaboration with ICOS without ICOS's written permission, unless required to do so by law, in which case Array shall promptly notify ICOS of such required disclosure and will use its reasonable efforts to assist ICOS to secure confidential treatment of such structure prior to any disclosure.
Appears in 1 contract
Samples: Cycle Checkpoint Optimization Agreement (Array Biopharma Inc)